Published in Ann N Y Acad Sci on July 10, 1952
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat Rev Microbiol (2008) 3.01
Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going? Viruses (2015) 0.92
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses. Viruses (2016) 0.83
Attempts to propagate type 2 Lansing, Y-SK and MEF strains of poliomyelitis virus in neoplastic mouse tissue cultures. J Bacteriol (1954) 0.75
Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas. Cytotherapy (2017) 0.75
Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition. Biomark Cancer (2016) 0.75
Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer. Front Oncol (2017) 0.75
Presage of oncolytic virotherapy for oral cancer with herpes simplex virus. Jpn Dent Sci Rev (2016) 0.75
Submicroscopic cytoplasmic particles occasionally found in the Ehrlich mouse ascites tumor. Cancer Res (1954) 4.67
Neoplastic changes developing in epithelial cell lines derived from normal persons. Science (1956) 3.81
Culture characteristics of four permanent lines of human cancer cells. Cancer Res (1955) 3.69
Induced virus infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg (1954) 2.64
Induced immunity to cancer cell homografts in man. Ann N Y Acad Sci (1958) 2.00
Homotransplantation of human cell lines. Science (1957) 1.67
West Nile, Ilheus, and Bunyamwera virus infections in man. Am J Trop Med Hyg (1951) 1.34
Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus. Cancer (1952) 1.21
Effects of viruses on tumors. Annu Rev Microbiol (1954) 1.08
Anti-virus antibody studies following induced infection of man with West Nile, Ilhéus, and other viruses. J Immunol (1954) 1.08
Folic acid analogs and experimental tumors. Ann N Y Acad Sci (1950) 1.06
Influence of hemagglutinating viruses on tumor cell suspensions. I. Growth inhibition and reversal of the effect. Proc Soc Exp Biol Med (1952) 1.02
H-1 VIRUS VIREMIA IN THE HUMAN. Proc Soc Exp Biol Med (1965) 0.98
Lactic dehydrogenase production in tissue culture of normal, transformed, and malignant human cell lines. Proc Soc Exp Biol Med (1959) 0.91
Oncolytic effect of Egypt virus on a human epidermoid carcinoma grown in x-irradiated rats. Proc Soc Exp Biol Med (1952) 0.90
Influence of hemagglutinating viruses on tumor cell suspensions. II. Newcastle disease virus and Ehrlich carcinoma. Proc Soc Exp Biol Med (1952) 0.88
Further studies on the destructive effect of the virus of Russian Far East encephalitis on the transplantable mouse sarcoma 180. Cancer (1950) 0.87
The destructive effect of the virus of Russian Far East encephalitis on the transplantable mouse sarcoma 180. Cancer (1949) 0.86
Changes in activity of Newcastle disease virus after adaption to Ehrlich ascites tissue culture. J Immunol (1956) 0.86
Tumorigenic activity of cultures. Ann N Y Acad Sci (1958) 0.85
Inhibition of growth of five transplantable mouse tumors by the virus of Russian Far East encephalitis. Cancer (1951) 0.84
Effect of inoculation of the viruses of influenza A and herpes simplex on the growth of transplantable tumors in mice. Cancer (1949) 0.83
Enhancement of oncolytic effect of Russian encephalitis virus. Proc Soc Exp Biol Med (1951) 0.81
Factors influencing the effect of hemagglutinating viruses on tumor cell suspensions. J Immunol (1953) 0.81
Inhibition of development of sarcoma 180 by 4-amino-N10-methyl pteroylglutamic acid. Proc Soc Exp Biol Med (1949) 0.77
The effect of aminopterin on the growth of carcinoma, sarcoma, and melanoma in animals. Cancer (1949) 0.77
The traction sigmoidoscope; development and preliminary report. Am J Surg (1955) 0.75
Traction sigmoidoscopy. Surg Clin North Am (1957) 0.75
Primary union in the operation for fistula-in-ano. N Z Med J (1950) 0.75
The destructive effects of viruses on transplantable mouse tumors. Acta Unio Int Contra Cancrum (1951) 0.75
Criteria of malignancy. II. Biological consideration of normal and abnormal cell lines. Trans N Y Acad Sci (1957) 0.75
Effect of folic acid on in vitro uptake of labeled thymidine by leukemic cells. Proc Soc Exp Biol Med (1961) 0.75
Traction sigmoidoscopy. Am J Surg (1956) 0.75
Heterologous growth of sarcoma 180 with progression to death of hosts. Cancer Res (1950) 0.75
Presidential address. N Z Med J (1946) 0.75
TUMORS OCCURRING IN NEWBORN MICE AFTER INOCULATION OF HUMAN CANCER MATERIAL. Cancer Res (1964) 0.75
Lactic dehydrogenase production in tissue culture of normal, transformed, and malignant human cell lines. Acta Unio Int Contra Cancrum (1960) 0.75
A case of double uterus with septate vagina. Aust N Z J Surg (1953) 0.75
CONSIDERATION OF MEANS FOR DETERMINING IF VIRUSES ARE CAUSALLY RELATED TO CANCER IN MAN. Prog Med Virol (1963) 0.75
Effect of 2,6-diaminopurine on the course of Russian spring-summer encephalitis infection in the mouse. Proc Soc Exp Biol Med (1951) 0.75
Latency of induced virus infection. Ann N Y Acad Sci (1957) 0.75
Improved legal procedure for the care of the mentally ill. J Mich State Med Soc (1947) 0.75
Tumour of the small bowel causing intussusception. N Z Med J (1945) 0.75
The oncolytic viruses. Prog Exp Tumor Res (1960) 0.75
The diagnosis of aminoaciduria in childhood: cystine storage disease and cystine-lysinuria. Med J Aust (1954) 0.75
Galactose intolerance: observations on an experimental animal. Acta Paediatr (1956) 0.75
Oncolytic properties of viruses. Tex Rep Biol Med (1957) 0.75
Sarcoma 180 inhibition screening data. Cancer Res (1953) 0.75
You never can tell; the problem of the childless marriage. Practitioner (1956) 0.75
Present status of oncolytic viruses and their effect on tumors in mouse, man and tissue culture. Acta Unio Int Contra Cancrum (1956) 0.75